Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.320
-0.390 (-22.81%)
At close: May 30, 2025, 4:00 PM
1.330
+0.010 (0.76%)
After-hours: May 30, 2025, 7:59 PM EDT
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $242.33 million as of May 30, 2025. Its market cap has decreased by -72.58% in one year.
Market Cap
242.33M
Enterprise Value
399.92M
1-Year Change
-72.58%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $242.33M, a decrease of -95.72%. That is a compound annual growth rate of -36.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 194.20M | -32.73% |
| Dec 31, 2024 | 288.70M | -31.86% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 648.68B |
| Johnson & Johnson | 369.52B |
| AbbVie | 327.88B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.48B |
| Abbott Laboratories | 231.14B |
| Novartis AG | 219.70B |
| AstraZeneca | 217.50B |